| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.4 |